Clinical Trials Logo

Pain clinical trials

View clinical trials related to Pain.

Filter by:

NCT ID: NCT00978549 Completed - Pain Clinical Trials

Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer

Start date: April 2008
Phase: Phase 3
Study type: Interventional

RATIONALE: Analgesics, antiemetics, steroids, and radiation therapy are effective in helping to control symptoms caused by cancer. It is not yet known whether these treatments are more effective when given with or without docetaxel in treating patients with relapsed esophageal cancer or stomach cancer. PURPOSE: This randomized phase II trial is studying symptom control given together with docetaxel to see how well it works compared with symptom control given without docetaxel in treating patients with relapsed esophageal cancer or stomach cancer.

NCT ID: NCT00978328 Completed - Pain Clinical Trials

Oxycodone User Registry (OUR)

Start date: June 2009
Phase: N/A
Study type: Observational

The purpose of this study is to describe clinical and demographic characteristics of patients receiving prescription medications containing oxycodone immediate release (OXYRX), to characterize patient and prescriber perceptions of the effectiveness outcomes and tolerability of OXYRX treatment, to describe prescriber decision-making about pain management with a Schedule II opioid and to explore how prescribers identify suspected abuse of pain medications.

NCT ID: NCT00977041 Completed - Pain Clinical Trials

Neurofeedback Treatment of Pain in Persons With Spinal Cord Injury (SCI)

Start date: August 2010
Phase: Phase 2
Study type: Interventional

A number of studies suggest that training to increase different types of brain waves is related to pain relief. The purpose of the second phase of this study is to see if neurofeedback training might help people with chronic pain control their pain better. The information from the study may help the investigators treat chronic pain better in the future.

NCT ID: NCT00976716 Completed - Pain Clinical Trials

An Open-Label Study Of Celecoxib In Patients With Posttraumatic Pain

Start date: September 2009
Phase: Phase 3
Study type: Interventional

To investigate efficacy, safety and tolerability of Celecoxib in patients with posttraumatic pain for the duration of 8 days.

NCT ID: NCT00974168 Completed - Pain Clinical Trials

Spinal Cord Compression Re-Treat Study

Start date: October 2007
Phase: Phase 2
Study type: Interventional

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Radiation therapy may be effective in treating malignant spinal cord compression in patients who have received previous radiation therapy to the spine. PURPOSE: This phase II trial is studying radiation therapy in treating patients with malignant spinal cord compression.

NCT ID: NCT00972634 Completed - Depression Clinical Trials

Computerized Questionnaires in Assessing Symptoms, Pain, Depression, and Physical Function in Patients With Metastatic and/or Advanced Locoregional Cancer

Start date: October 2008
Phase: N/A
Study type: Observational

RATIONALE: A computer-based system for assessing symptoms may be effective for patients with metastatic or advanced cancer. PURPOSE: This clinical trial is studying how well computerized questionnaires work in assessing symptoms, pain, depression, and physical function in patients with metastatic and/or advanced local/regional cancer.

NCT ID: NCT00971581 Completed - Pain Clinical Trials

Safety, Tolerability and Efficacy Study With a Fixed-Dose Combination (FDC) Ketoprofen Plus Omeprazole

Start date: August 2009
Phase: Phase 3
Study type: Interventional

Primary Objective: To confirm the safety and tolerability of the fixed dose combination of a Non-Steroidal Anti-Inflammatory Drug (NSAID), ketoprofen, associated to a Proton Pump Inhibitor (PPI), omeprazole, in Mexican patients. Secondary Objective: To confirm the efficacy of the combination: - Relief of pain (Visual Analyzed Score (VAS)) - Patients global assessment of disease activity, scored as a scale of 1 (no limitation of normal activities) to 5 (inability to carried out all normal activities)

NCT ID: NCT00969176 Completed - Pain Clinical Trials

Pharmacokinetics, -Dynamics and Safety of Intravenous Paracetamol in Neonates

PARANEO
Start date: September 2009
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is triple, i.e. document single dose pharmacokinetics and -dynamics of intravenous paracetamol in preterm and term neonates after a loading dose (20 mg/kg iv bolus paracetamol), document multiple dose pharmacokinetics and -dynamics of intravenous paracetamol in preterm and term neonates, based on the daily doses routinely used within the neonatal intensive care unit and as reported in literature. Finally, document safety of single and repeated dose of intravenous paracetamol in preterm and term neonates.

NCT ID: NCT00968175 Completed - Pain Clinical Trials

Endoscopic Ultrasound (EUS) Guided-Celiac Plexus Neurolysis (CPN) in Unresectable Pancreatic Cancer

Start date: June 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to examine endoscopic ultrasound guided celiac plexus neurolysis (CPN) with analgesic therapy in patients with unresectable pancreatic cancer as it applies to decreasing the severity of abdominal pain when compared to analgesic therapy alone.

NCT ID: NCT00957697 Completed - Pain Clinical Trials

Pain After Stroke, Part 2: Clinical Characteristics and Classification of Pain in Patients After Stroke

Start date: April 2008
Phase: N/A
Study type: Observational

The purpose of this study is to investigate the prevalence of characteristics of pain in a cohort of patients with prior stroke suspected of having central post stroke pain, identified through a postal questionnaire.